These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 34555640)
1. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8 Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640 [TBL] [Abstract][Full Text] [Related]
2. Th17 cells inhibit CD8 Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584 [TBL] [Abstract][Full Text] [Related]
3. Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma. Pan QZ; Pan K; Zhao JJ; Chen JG; Li JJ; Lv L; Wang DD; Zheng HX; Jiang SS; Zhang XF; Xia JC Cancer Immunol Immunother; 2013 Nov; 62(11):1675-85. PubMed ID: 24061617 [TBL] [Abstract][Full Text] [Related]
4. IL-17 inhibits CXCL9/10-mediated recruitment of CD8 Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909 [TBL] [Abstract][Full Text] [Related]
5. Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer. Sui Q; Liu D; Jiang W; Tang J; Kong L; Han K; Liao L; Li Y; Ou Q; Xiao B; Liu G; Ling Y; Chen J; Liu Z; Zuo Z; Pan Z; Zhou P; Zheng J; Ding PR J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33782107 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling. Roshani Asl E; Rasmi Y; Baradaran B J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473 [TBL] [Abstract][Full Text] [Related]
7. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer. Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141 [TBL] [Abstract][Full Text] [Related]
8. IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer? Chen F; Qu M; Zhang F; Tan Z; Xia Q; Hambly BD; Bao S; Tao K BMC Cancer; 2020 Feb; 20(1):92. PubMed ID: 32013927 [TBL] [Abstract][Full Text] [Related]
9. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer. Amicarella F; Muraro MG; Hirt C; Cremonesi E; Padovan E; Mele V; Governa V; Han J; Huber X; Droeser RA; Zuber M; Adamina M; Bolli M; Rosso R; Lugli A; Zlobec I; Terracciano L; Tornillo L; Zajac P; Eppenberger-Castori S; Trapani F; Oertli D; Iezzi G Gut; 2017 Apr; 66(4):692-704. PubMed ID: 26719303 [TBL] [Abstract][Full Text] [Related]
10. Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration. Zumwalt TJ; Arnold M; Goel A; Boland CR Oncotarget; 2015 Feb; 6(5):2981-91. PubMed ID: 25671296 [TBL] [Abstract][Full Text] [Related]
11. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925 [TBL] [Abstract][Full Text] [Related]
13. Th22 cell accumulation is associated with colorectal cancer development. Huang YH; Cao YF; Jiang ZY; Zhang S; Gao F World J Gastroenterol; 2015 Apr; 21(14):4216-24. PubMed ID: 25892871 [TBL] [Abstract][Full Text] [Related]
14. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors. Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-38 promotes tumor growth through regulation of CD8 Kinoshita F; Tagawa T; Akamine T; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Shimokawa M; Oda Y; Hoshino T; Mori M Cancer Immunol Immunother; 2021 Jan; 70(1):123-135. PubMed ID: 32653939 [TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133 [TBL] [Abstract][Full Text] [Related]
19. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer. Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y Front Immunol; 2021; 12():667177. PubMed ID: 34025668 [TBL] [Abstract][Full Text] [Related]
20. G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets. Karagiannidis I; Jerman SJ; Jacenik D; Phinney BB; Yao R; Prossnitz ER; Beswick EJ Front Immunol; 2020; 11():1885. PubMed ID: 33042110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]